Wang et al. (2015) reported elevated levels of CCL19 in valvular tissues from RHD patients, suggesting that chemokine-induced migratory activity of pro-inflammatory cells contributes to the development of valvular lesions [54]. The gene discussed is CCL19; the disease is rheumatic heart disease.